ライフサイエンスコーパス: nitrofurantoin

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 Both episodes responded to treatment with nitrofurantoin.

2 not to menadione, plumbagin, pyrogallol, or nitrofurantoin.

3 ased sensitivity to killing by bleomycin and nitrofurantoin.

4 e, moxifloxacin, cephalexin, diclofenac, and nitrofurantoin.

5 or 60 DILI cases with latency >365 days were nitrofurantoin (25%) or minocycline (17%).

6 6%), azathioprine (4%), infliximab (4%), and nitrofurantoin (4%).

7 CI, 184-718), and 1 of 1369 patients taking nitrofurantoin (73 of 100,000; 95% CI, 20-187).

8 hogens causing acute cystitis, resistance to nitrofurantoin and ciprofloxacin remained infrequent.

9 ubstrates include numerous drugs (topotecan, nitrofurantoin, cimetidine) as well as food carcinogens

10 Nitrofurantoin, furazolidone, furaltadone and nitrofuraz

11 In contrast, the prevalence of resistance to nitrofurantoin, gentamicin, and ciprofloxacin hydrochlor

12 r high-level gentamicin resistance and 1 for nitrofurantoin, in E. faecium isolates.

13 istance to trimethoprim-sulfamethoxazole and nitrofurantoin, it was more susceptible to ampicillin th

14 oxazole (160/800 mg twice daily for 3 days), nitrofurantoin monohydrate/macrocrystals (100 mg twice d

15 ferent antibiotics, gentamicin, ceftazidime, nitrofurantoin, nalidixic acid, ofloxacin.

16 or furaltadone (FTD), furazolidone (FZD) and nitrofurantoin (NFT).

17 ly significant) to all antimicrobials except nitrofurantoin (NIT) were higher in independent faciliti

18 therapy with trimethoprim-sulfamethoxazole, nitrofurantoin, or fosfomycin is indicated for acute cys

19 In the 3 UTIs/year model, nitrofurantoin prophylaxis was most effective, reducing

20 ical trials published: (1) daily antibiotic (nitrofurantoin) prophylaxis; (2) daily estrogen prophyla

21 tible to ceftaroline, daptomycin, linezolid, nitrofurantoin, quinupristin-dalfopristin, rifampin, tig

22 e literature, the activity of fosfomycin and nitrofurantoin remain high for most cases of MDR Escheri

23 Nitrofurantoin showed >80% susceptibility in all groups.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。